HCV genotypes expression in hepatocellular carcinoma by reverse transcription in situ polymerase chain reaction

Hao Ying,Neng Shi,Lun Shi,Hong Ying
DOI: https://doi.org/10.3969/j.issn.1009-3079.2000.08.008
2000-01-01
World Chinese Journal of Digestology
Abstract:AIM To study the relationship between hepatitis C virus (HCV) genotypes and development of hepatocellular carcinoma (HCC) at molecular pathologic level. METHODS Reverse transcription in situ polymerase chain reaction (RT-IS PCR) method was performed to detect genotypes 1b and 2a of HCV in HCC tissue and noncancerous area of 86 cases. HCV genotypes were simultaneously checked by Okamotos method using RNA extracts from HCC tissues. RESULTS The positivity of HCV in HCC tissue was 44% (42/95). Three HCV genotypes were detected, including 1b, 2a, mixed type (1b + 2a) and 3a in 13 (31%), 23 (55%), 2 (5%) and 4 (10%) cases respectively. There was no significant difference between positivities of genotypes 1b (14%) and 2a (24%) (X2 =3.427, P>0.05). And two genotypes showed similar correlation with main pathologic parameters of HCC. The distribution of genotype 2a-positive cells was similar in both cancerous and noncancerous areas. Cells with genotype 1b were prone to be focal in cancerous area and focal/ diffuse in noncancerous area. The positive nucleocytoplasmic/ nuclear signals of genotype 1b in HCC were seen more frequently than that of genotype 2a (X2 = 4.073, P<0.05). With omission of reverse transcription and with pretreatment of RNase A, the positive signal of genotypes 1b and 2a were still observed in 5 and 9 HCC cases respectively. CONCLUSION Two common HCV genotypes (1b and 2a) are similarly associated with HCC in China. The possibility of presence of HCV-related DNA and its integration into host genome could not be excluded.
What problem does this paper attempt to address?